Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc analysis of the PAILOT randomized controlled trial
- Manar Matar
- , Raanan Shamir
- , Dan Turner
- , Efrat Broide
- , Batia Weiss
- , Oren Ledder
- , Anat Guz-Mark
- , Firas Rinawi
- , Shlomi Cohen
- , Chani Topf-Olivestone
- , Ron Shaoul
- , Baruch Yerushalmi
- , Shomron Ben-Horin
- , Amit Assa*
*Corresponding author for this work
- Schneider Children's Hospital
- Hebrew University of Jerusalem
- Assaf Harofeh Medical Center
- Sheba Medical Center at Tel Hashomer
- Tel Aviv University
- Tel Aviv Sourasky Medical Center
- Kaplan Medical Center Israel
- Rambam Health Care Campus Israel
- Soroka Medical Center
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations